KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Moderna (MRNA) over the last 7 years, with Q3 2025 value amounting to $390.0 million.

  • Moderna's Shares Outstanding (Diluted Average) fell 225.56% to $390.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $390.0 million, marking a year-over-year decrease of 225.56%. This contributed to the annual value of $384.0 million for FY2024, which is 52.36% up from last year.
  • As of Q3 2025, Moderna's Shares Outstanding (Diluted Average) stood at $390.0 million, which was down 225.56% from $388.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Shares Outstanding (Diluted Average) registered a high of $434.0 million during Q3 2021, and its lowest value of $382.0 million during Q3 2023.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $403.9 million, with a median of $399.0 million in 2024.
  • In the last 5 years, Moderna's Shares Outstanding (Diluted Average) soared by 2181.3% in 2021 and then tumbled by 945.63% in 2023.
  • Moderna's Shares Outstanding (Diluted Average) (Quarter) stood at $431.0 million in 2021, then fell by 3.48% to $416.0 million in 2022, then dropped by 8.17% to $382.0 million in 2023, then rose by 0.52% to $384.0 million in 2024, then rose by 1.56% to $390.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $390.0 million in Q3 2025, compared to $388.0 million in Q2 2025 and $386.0 million in Q1 2025.